Pier 88 Investment Partners LLC Takes Position in Tempus AI, Inc. $TEM

Pier 88 Investment Partners LLC acquired a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the second quarter, Holdings Channel reports. The institutional investor acquired 4,500 shares of the company’s stock, valued at approximately $286,000.

A number of other institutional investors and hedge funds have also modified their holdings of TEM. ARK Investment Management LLC increased its holdings in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after buying an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. raised its holdings in shares of Tempus AI by 31.5% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after purchasing an additional 1,021,460 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong acquired a new stake in Tempus AI in the first quarter valued at $34,119,000. Finally, Massachusetts Financial Services Co. MA lifted its stake in Tempus AI by 92.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock worth $27,926,000 after purchasing an additional 278,311 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Price Performance

Shares of Tempus AI stock opened at $71.56 on Friday. The business’s fifty day moving average price is $85.91 and its 200 day moving average price is $71.02. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32. The company has a current ratio of 3.28, a quick ratio of 1.43 and a debt-to-equity ratio of 2.45. The stock has a market capitalization of $12.43 billion, a P/E ratio of -60.13 and a beta of 4.86.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.16) by $0.05. The company had revenue of $334.21 million during the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The firm’s revenue was up 84.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.46) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, research analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insider Transactions at Tempus AI

In other news, COO Ryan Fukushima sold 17,460 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the sale, the chief operating officer owned 839,180 shares of the company’s stock, valued at $62,644,787. This represents a 2.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm’s stock in a transaction on Thursday, September 25th. The shares were sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the completion of the transaction, the chief executive officer directly owned 9,141,032 shares in the company, valued at approximately $699,837,409.92. This represents a 3.51% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,105,282 shares of company stock valued at $87,726,381 in the last three months. 26.27% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

TEM has been the subject of a number of research analyst reports. TD Cowen cut Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price for the company. in a research report on Tuesday, October 21st. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. HC Wainwright reduced their target price on Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a report on Friday. Piper Sandler upped their price target on Tempus AI from $70.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, October 22nd. Finally, Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Seven investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $79.85.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.